In particular, abnormalities in glutamatergic and GABAergic neurotransmission across key brain regions such as the hippocampus, amygdala, and cerebellum may underlie several characteristic clinical features of ASD, including impairments in learning and memory, atypical visual perception (e.g., hypersensitivity to bright light), repetitive behaviors, and avoidance across social settings (157, 158)
and jointly recommended by professional organizations Developed and manufactured by
Used in Combination Therapy: BPC 157 is used in conjunction with other therapies to enhance and increase the results of treatments for various conditions, including ulcers, wound healing, and joint pain
Key Benefits observed: Body Composition Improvements Enhanced protein synthesis, granted lean muscle development, and increased strength Higher fat metabolism